Association of inflammatory response gene polymorphism with atherothrombotic stroke in Northern Han Chinese

Acta Biochimica et Biophysica Sinica

Volumn 44, Issue 12, 2012, Pages 1023-1030

  Zhao, Jiuhan ^a   Wang, Xiaohong ^a   Xu, Jialiang ^b   Li, Nan ^c   Shang, Xiuli ^a   He, Zhiyi ^a   Yang, Jun ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

^b Liaoning Province People Hospital   (China)

^c Jinzhou Central Hospital   (China)

Author keywords

ALOX5AP; atherothrombotic stroke; inflammation; PDE4D; polymorphism

Indexed keywords

ALOX5AP PROTEIN, HUMAN; ARACHIDONATE 5 LIPOXYGENASE ACTIVATING PROTEIN; INTERLEUKIN 1ALPHA; PDE4D PROTEIN, HUMAN; PHOSPHODIESTERASE III;

AGED; ALLELE; ARTICLE; ASIAN; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHINA; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; HAPLOTYPE; HUMAN; INFLAMMATION; MALE; MIDDLE AGED; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL MODEL; THROMBOSIS;

5-LIPOXYGENASE-ACTIVATING PROTEINS; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CHINA; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 3; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HAPLOTYPES; HUMANS; INFLAMMATION; INTERLEUKIN-1ALPHA; LOGISTIC MODELS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STROKE; THROMBOSIS;

EID: 84870160852     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1093/abbs/gms088     Document Type: Article

References (31)

1. Feigin VL, Lawes CM, Bennett DA and Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003, 2: 43-53.
2. Cheng J, Liu J, Li X, Yu L, Peng J, Zhang R and Geng Y, et al. Effect of polymorphisms of endothelial nitric oxide synthase on ischemic stroke: a casecontrol study in a Chinese population. Clin Chim Acta 2008, 392: 46-51.
3. Matarin M, Singleton A, Hardy J and Meschia J. The genetics of ischemic stroke. J Intern Med 2010, 267: 139-155.
4. Bak S, Gaist D, Sindrup SH, Skytthe A and Christensen K. Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke 2002, 33: 769-774.
5. Munshi A and Kaul S. Stroke genetics-focus on PDE4D gene. Int J Stroke 2008, 3: 188-192.
6. Spanbroek R, Grabner R, Lotzer K, Hildner M, Urbach A, Ruhling K and Moos MP, et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc Natl Acad Sci USA 2003, 100: 1238-1243.
7. Libby P. Inflammation in atherosclerosis. Nature 2002, 420: 868-874.
8. Jerrard-Dunne P, Sitzer M, Risley P, Buehler A, von Kegler S and Markus HS. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke 2004, 35: 2438-2443.
9. Jerrard-Dunne P, Sitzer M, Risley P, Steckel DA, Buehler A, von Kegler S and Markus HS. Interleukin-6 promoter polymorphism modulates the effects of heavy alcohol consumption on early carotid artery atherosclerosis: the Carotid Atherosclerosis Progression Study (CAPS). Stroke 2003, 34: 402-407.
10. Liu H, Palmer D, Jimmo SL, Tilley DG, Dunkerley HA, Pang SC and Maurice DH. Expression of phosphodiesterase 4D (PDE4D) is regulated by both the cyclic AMP-dependent protein kinase and mitogen-activated protein kinase signaling pathways. A potential mechanism allowing for the coordinated regulation of PDE4D activity and expression in cells. J Biol Chem 2000, 275: 26615-26624.
11. Rauramaa R, Vaisanen SB, Luong LA, Schmidt-Trucksass A, Penttila IM, Bouchard C and Toyry J, et al. Stromelysin-1 and interleukin-6 gene promoter polymorphisms are determinants of asymptomatic carotid artery atherosclerosis. Arterioscler Thromb Vasc Biol 2000, 20: 2657-2662.
12. Elneihoum AM, Falke P, Hedblad B, Lindgarde F and Ohlsson K. Leukocyte activation in atherosclerosis: correlation with risk factors. Atherosclerosis 1997, 131: 79-84.
13. Um JY, Moon KS, Lee KM, Yun JM, Cho KH, Moon BS and Kim HM. Association of interleukin-1 alpha gene polymorphism with cerebral infarction. Brain Res Mol Brain Res 2003, 115: 50-54.
14. Banerjee I, Gupta V, Ahmed T, Faizaan M, Agarwal P and Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: a casecontrol study in an Indian population. Brain Res Bull 2008, 75: 158-165.
15. Lõhmussaar E, Gschwendtner A, Mueller JC, Org T, Wichmann E, Hamann G and Meitinger T, et al. ALOX5AP gene and the PDE4D gene in a central European population of stroke patients. Stroke 2005, 36: 731-736.
16. Kaushal R, Pal P, Alwell K, Haverbusch M, Flaherty M, Moomaw C and Sekar P, et al. Association of ALOX5AP with ischemic stroke: a population-based case-control study. Hum Genet 2007, 121: 601-607.
17. Li N, He ZY, Xu JL, Liu F, Deng SM and Zhang H. Association of PDE4D and IL-1 gene polymorphism with ischemic stroke in a Han Chinese population. Brain Res Bull 2010, 81: 38-42.
18. Zee RY, Cheng S, Hegener HH, Erlich HA and Ridker PM. Genetic variants of arachidonate 5-lipoxygenase-activating protein, and risk of incident myocardial infarction and ischemic stroke: a nested case-control approach. Stroke 2006, 37: 2007-2011.
19. Meschia JF, Brott TG, Brown RD, Jr, Crook R, Worrall BB, Kissela B and Brown WM, et al. Phosphodiesterase 4D and 5-lipoxygenase activating protein in ischemic stroke. Ann Neurol 2005, 58: 351-361.
20. Helgadottir A, Gretarsdottir S, St Clair D, Manolescu A, Cheung J, Thorleifsson G and Pasdar A, et al. Association between the gene encoding 5-lipoxygenase-activating protein and stroke replicated in a Scottish population. Am J Hum Genet 2005, 76: 505-509.
21. Newcombe PJ, Verzilli C, Casas JP, Hingorani AD, Smeeth L and Whittaker JC. Multilocus Bayesian meta-analysis of gene-disease associations. Am J Hum Genet 2009, 84: 567-580.
22. Adams HP, Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL and Marsh EE, III. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172. in Acute Stroke Treatment. Stroke 1993, 24: 35-41.
23. Helgadottir A, Manolescu A, Thorleifsson G, Gretarsdottir S, Jonsdottir H, Thorsteinsdottir U and Samani NJ, et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nat Genet 2004, 36: 233-239.
24. Zhang WL, Yang XM, Shi J, Sun K and Hui RT. Polymorphism of SG13S114T/A in the ALOX5AP gene and the risk for stroke in a large Chinese cohort. Yi Chuan Xue Bao 2006, 33: 678-684.
25. Wang G, Wang Y, Sun H, Cao W, Zhang J, Xiao H and Zhang J. Variants of the arachidonate 5-lipoxygenase-activating protein (ALOX5AP) gene and risk of ischemic stroke in Han Chinese of eastern China. J Biomed Res 2011, 25: 319-327.
26. Kario K, Matsuo T, Kobayashi H, Asada R and Matsuo M. 'Silent' cerebral infarction is associated with hypercoagulability, endothelial cell damage, and high Lp(a) levels in elderly Japanese. Arterioscler Thromb Vasc Biol 1996, 16: 734-741.
27. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PH and Polak JF, et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: The Cardiovascular Health Study. Circulation 2003, 108: 166-170.
28. Saleheen D, Bukhari S, Haider SR, Nazir A, Khanum S, Shafqat S and Anis MK, et al. Association of phosphodiesterase 4D gene with ischemic stroke in a Pakistani population. Stroke 2005, 36: 2275-2277.
29. Staton JM, Sayer MS, Hankey GJ, Attia J, Thakkinstian A, Yi Q and Cole VJ, et al. Association between phosphodiesterase 4D gene and ischaemic stroke. J Neurol Neurosurg Psychiatry 2006, 77: 1067-1069.
30. Banerjee J, Gupta V, Ahmad T, Faizaan M, Agarwal P and Ganesh S. Inflammatory system gene polymorphism and the risk of stroke: a case control study in an Indian population. Brain Res Bull 2008, 75: 158-165.
31. Brophy VH, Ro SK, Rhees BK, Lui LY, Lee JM, Umblas N and Bentley LG, et al. Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a US population stratified by hypertension status. Stroke 2006, 37: 1385-1390.